TFA
BCAB icon

Toth Financial Advisory’s BioAtla BCAB Stock Holding History

Toth Financial Advisory’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10
Closed -$880 – 704
2024
Q3 		$880 Hold
10
– – ﹤0.01% 674
2024
Q2 		$685 Hold
10
– – ﹤0.01% 714
2024
Q1 		$1.72K Buy
+10
New +$1.24K ﹤0.01% 619

Other funds holding BCAB

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Toth Financial Advisory's BCAB Position: Q4 2024 in Review

Toth Financial Advisory sold out of BioAtla (BCAB) in Q4 2024, closing a stake of 10 shares — an estimated $880 sold.

Toth Financial Advisory first reported a position in BCAB in Q1 2024 and held it in 3 quarters. The position peaked at $1.72K in Q1 2024. 67 funds tracked by Wall St. Rank hold BCAB as of Q4 2024.

  • Toth Financial Advisory reported no remaining BioAtla position as of Q4 2024 after selling out during the quarter.
  • Toth Financial Advisory sold 10 BioAtla shares in Q4 2024, an estimated $880.
  • Toth Financial Advisory first reported a position in BioAtla in Q1 2024 and held it in 3 quarters.
  • Toth Financial Advisory's BioAtla position peaked at $1.72K in Q1 2024.
  • 67 funds tracked by Wall St. Rank held BioAtla as of Q4 2024.

Based on Toth Financial Advisory's 13F filing for Q4 2024, filed 21 Jan 2025.